Stay updated on Efficacy of EID Natalizumab in RRMS Clinical Trial
Sign up to get notified when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.

Latest updates to the Efficacy of EID Natalizumab in RRMS Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a newer build of the page/template. This is a software/documentation update rather than a change to the study content or results.SummaryDifference0.0%

- Check13 days agoChange DetectedAdded an NIH funding reference '2018 ( U.S. NIH Grant/Contract )' under Other Study ID Numbers, indicating U.S. NIH support for the study. This clarifies the study's funding source and provenance.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a minor version update to the page assets or documentation.SummaryDifference0.0%

- Check41 days agoChange DetectedThe site shows a revision upgrade from v3.6.3 to v3.6.4, indicating a minor release. It does not modify the study details or other user-facing content on the page.SummaryDifference0.0%

- Check63 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, indicating a new page revision. This implies minor internal updates with no user-visible changes to content or functionality.SummaryDifference0.0%

- Check70 days agoChange DetectedThe page shows a newer revision tag, updating from v3.6.0 to v3.6.2, indicating an updated version of the study details page.SummaryDifference0.0%

Stay in the know with updates to Efficacy of EID Natalizumab in RRMS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of EID Natalizumab in RRMS Clinical Trial page.